Skip to Main Content
TABLE 3

Measures by Intervention Period

Baseline (n = 157)Intervention (n = 249)P
Outcome measures, n (%)    
 Discharge medication–related failures 110 (70.1) 90 (36.1) <.001 
 Discharge medication–related failures, excluding side effects 72 (45.9) 44 (17.7) <.001 
Process measures, n (%)    
 AVS information complete 33 (21.0) 212 (85.1) <.001 
 Consistent chart present 149 (94.9) 238 (95.6) .75 
 Simplified dosing present 118 (75.2) 238 (95.6) <.001 
 Used MEDRITES smart phrases NA 178 (71.5) NA 
Balancing measure, median (IQR)    
 LOS, h 48.0 (31.9 to 75.1) 39.1 (27.1 to 60.0) .002 
Baseline (n = 157)Intervention (n = 249)P
Outcome measures, n (%)    
 Discharge medication–related failures 110 (70.1) 90 (36.1) <.001 
 Discharge medication–related failures, excluding side effects 72 (45.9) 44 (17.7) <.001 
Process measures, n (%)    
 AVS information complete 33 (21.0) 212 (85.1) <.001 
 Consistent chart present 149 (94.9) 238 (95.6) .75 
 Simplified dosing present 118 (75.2) 238 (95.6) <.001 
 Used MEDRITES smart phrases NA 178 (71.5) NA 
Balancing measure, median (IQR)    
 LOS, h 48.0 (31.9 to 75.1) 39.1 (27.1 to 60.0) .002 

Categorical variables are presented as n (%) and analyzed with the χ2 test; continuous variables are presented as median (IQR) and analyzed with the Wilcoxon rank test. IQR, interquartile range; NA, not applicable.

Close Modal

or Create an Account

Close Modal
Close Modal